Beyond the Molecule: Supporting Oncologists and Patients in the Age of AI
Today’s healthcare environment is marked by rapid drug advancements, evolving patient expectations, and increasing pressures on healthcare professionals (HCPs) to deliver high-quality care.
From Noise to Value: Ending Content Overload for Physicians
As seen in Medical Expo How Ethical AI Can Transform Clinical Decision-Making and Restore Trust in Healthcare Engagement Physicians today face a paradox: they are surrounded by more medical information than ever, yet often struggle to access the pertinent insights they need, when they need them. From clinical guidelines and journal articles to EHR alerts […]
What banning direct-to-consumer pharma ads would mean for doctors
As seen in Medical Economics When U.S. Health and Human Services Secretary Robert F. Kennedy Jr. signaled support for curbing or ending direct-to-consumer (DTC) prescription drug advertising, and senators introduced a bill to prohibit it, the policy debate suddenly felt very close to the exam room. Our thesis is straightforward: a ban would not quiet pharmaceutical ad promotion so much […]
What the FDA’s DTC drug ad crackdown means for pharma companies
As seen in TechTarget As the FDA and HHS rein in direct-to-consumer drug advertising, new compliance rules and AI-driven monitoring could require some pharma companies to rethink their marketing approach. President Trump signed a memorandum, on Sept. 9, directing HHS, “to ensure transparency and accuracy in direct-to-consumer prescription drug advertising including by increasing the amount of information […]
Fortune Media and Great Place To Work Name Impiricus to 2025 Best Workplaces in Health Care List
Sept. 11, New York, NY — Great Place To Work® and Fortune magazine have selected Impiricus for the 2025 Fortune Best Workplaces in Health Care™ List. Earning a spot means that Impiricus is one of the best companies to work for in the country. “Being named one of Fortune’s Best Workplaces in Health Care is […]
Impiricus CEO Sandy Donaldson on the Future of Pharma Marketing Amid Potential TV Ad Ban
As the pharmaceutical industry faces mounting pressure from Washington over direct-to-consumer (DTC) advertising, Impiricus CEO Sandy Donaldson is helping lead the conversation on how brands can adapt and thrive in a rapidly evolving regulatory landscape. In a recent feature by Medical Marketing & Media (MM+M), Sandy was interviewed alongside other industry leaders about the growing […]
Reimagining pharma-HCP connections: AI, clinical support and the future of field force engagement
In this special episode of the MM+M Podcast, we sit down with Dr. Osama Hashmi alongside practicing physician Dr. Ahmed to explore how artificial intelligence is transforming the way healthcare professionals connect with pharmaceutical resources. In this special episode of the MM+M Podcast, we sit down with Dr. Osama Hashmi — dermatologist, cofounder and chief product officer […]
Impiricus Speaks at Innovation in 2025 Hosted by Solli
Our SVP of Product, Mike Gelber, recently participated in solli’s “Innovation in 2025” roundtable alongside leaders from Bayer, Dermavant Sciences, an Organon company, Novo Nordisk, Genco Pura Media LLC, CMI Media Group and PulsePoint. The agenda tackled some of the most pressing and exciting topics shaping our industry:– Real-world applications and ethical boundaries of AI– […]
Small Community Matters: Remote HCP Engagement Solved with Pfizer and Regeneron
Revolutionizing Pharma Marketing Through Self Curated Engagement
Impiricus Earns 2025 Great Place To Work Certification™
[Atlanta, Georgia] — Impiricus, the fastest growing AI solution for HCP engagement, is proud to be officially Certified™ as a Great Place To Work®. This prestigious recognition is based entirely on what current employees say about their experience working at Impiricus. This year, 100% of employees reported feeling welcomed, and the company surpassed the Great […]